Yorktown Management & Research Co Inc - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Yorktown Management & Research Co Inc ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q3 2018$320,000
-19.4%
4,0000.0%0.09%
-18.3%
Q2 2018$397,000
+22.5%
4,0000.0%0.12%
+19.8%
Q1 2018$324,0004,0000.10%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
Kite Lake Capital Management (UK) LLP 207,382$24,135,00076.46%
Maso Capital Partners Ltd 539,597$62,798,00020.20%
York Capital Management Global Advisors, LLC 1,102,163$128,270,0007.40%
HHLR ADVISORS, LTD. 2,751,200$320,185,0003.99%
Dalton Investments, Inc. 15,551$1,810,0001.14%
Athos Capital Ltd 8,290$965,0000.96%
Myriad Asset Management Ltd. 67,019$7,799,0000.94%
Temasek Holdings (Private) Ltd 990,000$115,216,0000.75%
OXFORD ASSET MANAGEMENT LLP 211,646$24,631,0000.68%
AGF Investments America Inc. 12,230$1,423,0000.47%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders